WHO nominates current head Chan for second term

January 18, 2012 in Health

The World Health Organisation on Wednesday nominated its current chief Margaret Chan for a second term at the head of the UN agency.

Director-General Chan was the only candidate put forward to the WHO's executive board who made the official nomination at a meeting in Geneva.

The appointment must be approved at the 65th World Health Assembly, scheduled to meet in the city from May 21-26.

"If confirmed by the , Dr Chan's new term will begin on July 1, 2012 and continue until June 30, 2017," WHO said.

Chan, a former Hong Kong health chief, was elected to the WHO's top post in November 2006.

During her Hong Kong tenure the city dealt with the world's first outbreak of the deadly virus as well as an outbreak of Severe Acute Respiratory Syndrome (SARS).

And in 2009, during her time at the helm of the WHO, Chan declared swine flu the world's first flu pandemic in 40 years.

(c) 2012 AFP

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Calorie information in fast food restaurants used by 40 percent of 9-18 year olds when making food choices

A new study published online today (Thursday) in the Journal of Public Health has found that of young people who visited fast food or chain restaurants in the U.S. in 2010, girls and youth who were obese were more likely ...

Health created 2 hours ago | popularity not rated yet | comments 0

Systematic screening of med adherence will ID barriers

(HealthDay)—Implementation of systematic monitoring for medication adherence will allow for identification of barriers to adherence and tailoring of interventions, according to a viewpoint piece published ...

Health created 4 hours ago | popularity not rated yet | comments 0

More doctors, hospitals using electronic records

(AP)—The Obama administration says more doctors and hospitals are embracing technology as adoption of computerized medical records reaches a "tipping point" in America.

Health created 5 hours ago | popularity not rated yet | comments 0

Hospitals profit when patients develop bloodstream infections

Johns Hopkins researchers report that hospitals may be reaping enormous income for patients whose hospital stays are complicated by preventable bloodstream infections contracted in their intensive care units.

Health created 5 hours ago | popularity not rated yet | comments 0

Alleviating hunger in the US, it's a SNAP, researcher says

A University of Illinois researcher says that the cornerstone of our efforts to alleviate food insecurity should be to encourage more people to participate in the Supplemental Nutrition Assistance Program (SNAP) "because ...

Health created 6 hours ago | popularity not rated yet | comments 0


Slowing the aging process—only with antibiotics

Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.

Researchers complete largest genetic sequencing study of human disease

Researchers from Queen Mary, University of London have led the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases.

Having both migraines, depression may mean smaller brain

(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.

Brain can be trained in compassion, study shows

Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.

Novel approach for influenza vaccination shows promise in early animal testing

A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...

Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis

In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe ...